ArticleLeukemia & lymphoma2020
Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection.
Claudio Galvao de Castro et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this paperpooled ittrialcites it